ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,049Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 15

$241K Total Retail Price of All Prescriptions

Rank: 4 out of 15

359 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 359 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 5,251 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 384 315 1 2
AMLODIPINE BESYLATE 298 267 2 5
SIMVASTATIN 246 213 3 3
HYDROCODONE-ACETAMINOPHEN 222 173 S3 4 1
PRAVASTATIN SODIUM 211 181 5 16
METFORMIN HCL 207 168 6 6
LOVASTATIN 197 195 7 14
LEVOTHYROXINE SODIUM 181 163 8 4
ATENOLOL 111 108 9 9
OMEPRAZOLE 106 90 10 7
METOPROLOL TARTRATE 106 95 10 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 92 12 23
ALENDRONATE SODIUM 103 101 13 20
RANITIDINE HCL 98 91 14 27
FUROSEMIDE 93 69 15 8
ZETIA 90 79 16 63
CARVEDILOL 86 70 17 24
DOXAZOSIN MESYLATE 86 86 17 64
GLYBURIDE-METFORMIN HCL 86 86 R 17 64
FINASTERIDE 84 84 20 50
HYDROCHLOROTHIAZIDE 79 71 21 11
LOSARTAN POTASSIUM 78 67 22 17
GLIPIZIDE 70 61 23 33
FLUTICASONE PROPIONATE 68 47 24 32
ALLOPURINOL 65 65 25 21
CLONIDINE HCL 63 46 26 41
PREDNISONE 62 54 27 30
METOPROLOL SUCCINATE 61 47 28 26
FENOFIBRATE 59 48 29 79
MELOXICAM 54 47 30 36
CIPROFLOXACIN HCL 52 48 31 40
LOSARTAN-HYDROCHLOROTHIAZIDE 51 46 32 46
IBUPROFEN 50 43 33 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.